stopwords, and 2-character and smaller words are excluded
TICAM-1, an adaptor molecule that participates in Toll-like
receptor 3-mediated interferon-beta induction
Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T
NATURE IMMUNOLOGY 4 (2): 161-167 FEB 2003
and the citing papers
Total: 668, Nodes: 194, Word count: 1792, All words count: 2511
View: Overview. Sorted by LCS.
Page 2 of 4: [ 1 2 3 4 ]
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 201 | SATURATED | 3 | 1.5 | 4 | 26
|
| 202 | SENSING | 2 | 1.0 | 4 | 16
|
| 203 | SER | 1 | 0.5 | 4 | 11
|
| 204 | SUBUNIT | 1 | 0.5 | 4 | 7
|
| 205 | TARGET | 2 | 1.0 | 4 | 12
|
| 206 | TRANSDUCERS | 1 | 0.5 | 4 | 57
|
| 207 | ACIDS | 2 | 1.0 | 3 | 17
|
| 208 | AGONISTS | 2 | 1.0 | 3 | 23
|
| 209 | AKT | 1 | 0.5 | 3 | 17
|
| 210 | ANALYSIS | 2 | 1.0 | 3 | 19
|
| 211 | APOPTOSIS | 4 | 2.1 | 3 | 11
|
| 212 | DEVELOPMENT | 3 | 1.5 | 3 | 22
|
| 213 | EBOLA | 1 | 0.5 | 3 | 28
|
| 214 | FAMILIES | 1 | 0.5 | 3 | 19
|
| 215 | HELMINTH | 2 | 1.0 | 3 | 21
|
| 216 | I-KAPPA | 1 | 0.5 | 3 | 7
|
| 217 | INTERFERON-STIMULATED | 1 | 0.5 | 3 | 6
|
| 218 | LAMBDA | 1 | 0.5 | 3 | 18
|
| 219 | MEKK | 1 | 0.5 | 3 | 14
|
| 220 | MODULATION | 3 | 1.5 | 3 | 27
|
| 221 | MONOCYTE-DERIVED | 1 | 0.5 | 3 | 18
|
| 222 | N1L | 1 | 0.5 | 3 | 7
|
| 223 | NECROSIS | 3 | 1.5 | 3 | 17
|
| 224 | ORTHOLOG | 1 | 0.5 | 3 | 19
|
| 225 | PHOSPHATIDYLINOSITOL | 1 | 0.5 | 3 | 17
|
| 226 | POXVIRUS | 1 | 0.5 | 3 | 7
|
| 227 | PROCESSOR | 1 | 0.5 | 3 | 14
|
| 228 | RECIPROCAL | 1 | 0.5 | 3 | 17
|
| 229 | RNAS | 2 | 1.0 | 3 | 22
|
| 230 | SARM | 1 | 0.5 | 3 | 19
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 231 | SIGNAL | 6 | 3.1 | 3 | 25
|
| 232 | SUPERFAMILY | 1 | 0.5 | 3 | 7
|
| 233 | TARGETS | 4 | 2.1 | 3 | 11
|
| 234 | TLR-INDEPENDENT | 1 | 0.5 | 3 | 19
|
| 235 | TRANSDUCTION | 5 | 2.6 | 3 | 22
|
| 236 | TRANSDUCTIONAL-TRANSCRIPTIONAL | 1 | 0.5 | 3 | 14
|
| 237 | TRIF-INDUCED | 2 | 1.0 | 3 | 6
|
| 238 | TYROSINE | 2 | 1.0 | 3 | 10
|
| 239 | ZEBRAFISH | 2 | 1.0 | 3 | 19
|
| 240 | ACTIVATED | 1 | 0.5 | 2 | 12
|
| 241 | ADAPTIVE | 7 | 3.6 | 2 | 12
|
| 242 | ADAPTOR-INDUCING | 1 | 0.5 | 2 | 4
|
| 243 | ADJUVANT | 1 | 0.5 | 2 | 12
|
| 244 | ADJUVANT-MEDIATED | 1 | 0.5 | 2 | 2
|
| 245 | BCG | 3 | 1.5 | 2 | 8
|
| 246 | CANCER | 1 | 0.5 | 2 | 12
|
| 247 | CDNA | 1 | 0.5 | 2 | 5
|
| 248 | CLEAVAGE | 1 | 0.5 | 2 | 5
|
| 249 | CONSERVED | 1 | 0.5 | 2 | 8
|
| 250 | CUTTING | 2 | 1.0 | 2 | 5
|
| 251 | CYTOKINE | 3 | 1.5 | 2 | 20
|
| 252 | CYTOTOXIC | 2 | 1.0 | 2 | 2
|
| 253 | DENDRITIC-CELL | 1 | 0.5 | 2 | 62
|
| 254 | DIFFERENTIATION | 4 | 2.1 | 2 | 33
|
| 255 | DIRECTLY | 1 | 0.5 | 2 | 12
|
| 256 | DISPLAY | 1 | 0.5 | 2 | 5
|
| 257 | EDGE | 2 | 1.0 | 2 | 5
|
| 258 | EVASION | 1 | 0.5 | 2 | 5
|
| 259 | EXPANDING | 1 | 0.5 | 2 | 8
|
| 260 | EXPRESSED | 1 | 0.5 | 2 | 5
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 261 | FAMILY | 3 | 1.5 | 2 | 10
|
| 262 | FLAGELLIN | 2 | 1.0 | 2 | 12
|
| 263 | FULL-SCALE | 1 | 0.5 | 2 | 19
|
| 264 | GENES | 3 | 1.5 | 2 | 6
|
| 265 | GLYCAN | 1 | 0.5 | 2 | 18
|
| 266 | HEPATITIS | 2 | 1.0 | 2 | 5
|
| 267 | IDENTIFIED | 1 | 0.5 | 2 | 5
|
| 268 | IFN-ALPHA | 3 | 1.5 | 2 | 18
|
| 269 | IMMUNOTHERAPY | 2 | 1.0 | 2 | 13
|
| 270 | IMPAIRED | 2 | 1.0 | 2 | 14
|
| 271 | INFLAMMATORY | 4 | 2.1 | 2 | 29
|
| 272 | INTERFERING | 1 | 0.5 | 2 | 19
|
| 273 | INTERFERON-GAMMA | 1 | 0.5 | 2 | 19
|
| 274 | LIGANDS | 2 | 1.0 | 2 | 12
|
| 275 | LINKING | 2 | 1.0 | 2 | 14
|
| 276 | MATURATION | 2 | 1.0 | 2 | 18
|
| 277 | MEDIATE | 2 | 1.0 | 2 | 21
|
| 278 | MEDIATES | 2 | 1.0 | 2 | 25
|
| 279 | MICE | 4 | 2.1 | 2 | 21
|
| 280 | MYD88-DEFICIENT | 2 | 1.0 | 2 | 4
|
| 281 | MYD88-DEPENDENT | 3 | 1.5 | 2 | 4
|
| 282 | MYD88-LIKE | 1 | 0.5 | 2 | 8
|
| 283 | PATHOGEN-DRIVEN | 1 | 0.5 | 2 | 62
|
| 284 | PHENOTYPE | 1 | 0.5 | 2 | 18
|
| 285 | POLARIZATION | 2 | 1.0 | 2 | 75
|
| 286 | PRIMES | 1 | 0.5 | 2 | 19
|
| 287 | PROGRAM | 2 | 1.0 | 2 | 16
|
| 288 | PROMOTE | 1 | 0.5 | 2 | 12
|
| 289 | PROMOTES | 1 | 0.5 | 2 | 10
|
| 290 | PROTEASE-MEDIATED | 1 | 0.5 | 2 | 5
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 291 | REGRESSION | 1 | 0.5 | 2 | 2
|
| 292 | RESISTANCE | 3 | 1.5 | 2 | 20
|
| 293 | SEQUENCE-INDEPENDENT | 2 | 1.0 | 2 | 25
|
| 294 | SMALL | 1 | 0.5 | 2 | 19
|
| 295 | SUBTRACTION | 1 | 0.5 | 2 | 5
|
| 296 | SUPPRESSION | 2 | 1.0 | 2 | 25
|
| 297 | SURVIVAL | 1 | 0.5 | 2 | 12
|
| 298 | T-CELL | 1 | 0.5 | 2 | 62
|
| 299 | TH2-TYPE | 1 | 0.5 | 2 | 10
|
| 300 | TLR4-AND | 1 | 0.5 | 2 | 15
|
| 301 | TNFR-ASSOCIATED | 1 | 0.5 | 2 | 4
|
| 302 | TRANSCRIPTIONAL | 5 | 2.6 | 2 | 10
|
| 303 | TRIF-DEPENDENT | 1 | 0.5 | 2 | 15
|
| 304 | TUBERCULOSIS | 1 | 0.5 | 2 | 19
|
| 305 | TUMOR-SPECIFIC | 1 | 0.5 | 2 | 2
|
| 306 | USES | 1 | 0.5 | 2 | 18
|
| 307 | WALL-SPECIFIC | 1 | 0.5 | 2 | 5
|
| 308 | ACID | 2 | 1.0 | 1 | 9
|
| 309 | ACTIVATE | 1 | 0.5 | 1 | 3
|
| 310 | AFFERENT | 1 | 0.5 | 1 | 3
|
| 311 | APOPTOTIC | 1 | 0.5 | 1 | 2
|
| 312 | APPROPRIATION | 1 | 0.5 | 1 | 2
|
| 313 | ARTHRITIS | 1 | 0.5 | 1 | 15
|
| 314 | ASTROCYTES | 2 | 1.0 | 1 | 1
|
| 315 | BACTERIA | 1 | 0.5 | 1 | 2
|
| 316 | BLOCK | 1 | 0.5 | 1 | 24
|
| 317 | BOVINE | 1 | 0.5 | 1 | 24
|
| 318 | BRIDGE | 1 | 0.5 | 1 | 6
|
| 319 | C-JUN | 1 | 0.5 | 1 | 1
|
| 320 | CASCADES | 1 | 0.5 | 1 | 3
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 321 | CHEMOKINES | 1 | 0.5 | 1 | 1
|
| 322 | CONTROLS | 2 | 1.0 | 1 | 7
|
| 323 | CPG | 3 | 1.5 | 1 | 16
|
| 324 | CYTOKINES | 5 | 2.6 | 1 | 13
|
| 325 | CYTOPLASMIC | 1 | 0.5 | 1 | 5
|
| 326 | DIMERIZED | 1 | 0.5 | 1 | 9
|
| 327 | DISEASES | 1 | 0.5 | 1 | 13
|
| 328 | DISSECTION | 1 | 0.5 | 1 | 3
|
| 329 | DSRNA | 3 | 1.5 | 1 | 7
|
| 330 | EVITHELIAL | 1 | 0.5 | 1 | 2
|
| 331 | FADD-DEPENDENT | 1 | 0.5 | 1 | 7
|
| 332 | GENETIC | 3 | 1.5 | 1 | 3
|
| 333 | HETEROGENEOUS | 1 | 0.5 | 1 | 15
|
| 334 | HOST | 4 | 2.1 | 1 | 14
|
| 335 | IFNS | 2 | 1.0 | 1 | 14
|
| 336 | IMPLICATIONS | 2 | 1.0 | 1 | 15
|
| 337 | INDIRECTLY | 1 | 0.5 | 1 | 3
|
| 338 | INFECTIOUS | 1 | 0.5 | 1 | 13
|
| 339 | INFLUENZA | 1 | 0.5 | 1 | 2
|
| 340 | INTERSECTION | 1 | 0.5 | 1 | 2
|
| 341 | INVOLVEMENT | 2 | 1.0 | 1 | 2
|
| 342 | LIFE | 1 | 0.5 | 1 | 37
|
| 343 | LINKER | 1 | 0.5 | 1 | 5
|
| 344 | LUNG | 2 | 1.0 | 1 | 9
|
| 345 | MACROPHAGE | 2 | 1.0 | 1 | 13
|
| 346 | MAMMALIAN | 1 | 0.5 | 1 | 7
|
| 347 | MATRIX | 1 | 0.5 | 1 | 15
|
| 348 | METALLOPROTEINASE | 1 | 0.5 | 1 | 15
|
| 349 | MODULATING | 1 | 0.5 | 1 | 10
|
| 350 | MYD88-DINDEPENDENT | 1 | 0.5 | 1 | 3
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 351 | N-TERMINAL | 1 | 0.5 | 1 | 1
|
| 352 | NEUTROPHIL | 1 | 0.5 | 1 | 37
|
| 353 | NOD | 1 | 0.5 | 1 | 13
|
| 354 | NONSTRUCTURAL | 1 | 0.5 | 1 | 24
|
| 355 | ODN-MEDIATED | 1 | 0.5 | 1 | 1
|
| 356 | OLIGODEOXYNUCLEOTIDES | 1 | 0.5 | 1 | 1
|
| 357 | PARASITE | 1 | 0.5 | 1 | 3
|
| 358 | PREDOMINANTLY | 1 | 0.5 | 1 | 3
|
| 359 | PRODUCTION | 4 | 2.1 | 1 | 29
|
| 360 | PROINFLAMMATORY | 2 | 1.0 | 1 | 13
|
| 361 | REGION | 1 | 0.5 | 1 | 5
|
| 362 | REGULATE | 2 | 1.0 | 1 | 9
|
| 363 | RESPIRATORY | 2 | 1.0 | 1 | 24
|
| 364 | RHEUMATOID | 1 | 0.5 | 1 | 15
|
| 365 | RIBONUCLEOPROTEIN | 1 | 0.5 | 1 | 7
|
| 366 | SCHISTOSOMA | 1 | 0.5 | 1 | 3
|
| 367 | SELECTIVE | 1 | 0.5 | 1 | 37
|
| 368 | SEPSIS | 2 | 1.0 | 1 | 6
|
| 369 | SOCS | 1 | 0.5 | 1 | 3
|
| 370 | SPAN | 1 | 0.5 | 1 | 37
|
| 371 | STOMATITIS | 1 | 0.5 | 1 | 7
|
| 372 | SUPPRESSOR | 1 | 0.5 | 1 | 3
|
| 373 | SYNCYTIAL | 2 | 1.0 | 1 | 24
|
| 374 | TARGETING | 1 | 0.5 | 1 | 13
|
| 375 | THERAPEUTIC | 2 | 1.0 | 1 | 15
|
| 376 | THERAPY | 1 | 0.5 | 1 | 15
|
| 377 | UTILIZES | 1 | 0.5 | 1 | 3
|
| 378 | VACCINE | 1 | 0.5 | 1 | 10
|
| 379 | VESICULAR | 1 | 0.5 | 1 | 7
|
| 380 | A46R | 1 | 0.5 | 0 | 1
|
| # | Word | Pubs | Percent | TLCS | TGCS
|
|---|
| 381 | ABSENCE | 1 | 0.5 | 0 | 3
|
| 382 | ACID-MEDIATED | 1 | 0.5 | 0 | 3
|
| 383 | ACQUIRED | 1 | 0.5 | 0 | 1
|
| 384 | ACTION | 1 | 0.5 | 0 | 0
|
| 385 | ACTIVITIES | 1 | 0.5 | 0 | 10
|
| 386 | ACTIVITY | 1 | 0.5 | 0 | 0
|
| 387 | ACUTE | 1 | 0.5 | 0 | 12
|
| 388 | ADJUVANCY | 1 | 0.5 | 0 | 1
|
| 389 | AIRWAY | 1 | 0.5 | 0 | 1
|
| 390 | ALLERGIC | 1 | 0.5 | 0 | 0
|
| 391 | ALLOGRAFTS | 1 | 0.5 | 0 | 3
|
| 392 | ALLOIMMUNITY | 1 | 0.5 | 0 | 1
|
| 393 | ALLOWS | 2 | 1.0 | 0 | 10
|
| 394 | ALTERNATE | 1 | 0.5 | 0 | 0
|
| 395 | ALTERNATIVE | 1 | 0.5 | 0 | 0
|
| 396 | ANIMAL | 1 | 0.5 | 0 | 0
|
| 397 | ANTAGONISTS | 1 | 0.5 | 0 | 4
|
| 398 | ANTI-INFLAMMATORY | 1 | 0.5 | 0 | 1
|
| 399 | ANTICIPATED | 1 | 0.5 | 0 | 0
|
| 400 | ANTIFUNGAL | 1 | 0.5 | 0 | 0
|
Page 2 of 4: [ 1 2 3 4 ]